Exact Sciences (EXAS) Cash from Operations: 2009-2025
Historic Cash from Operations for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $219.9 million.
- Exact Sciences' Cash from Operations rose 58.54% to $219.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $386.8 million, marking a year-over-year increase of 66.00%. This contributed to the annual value of $210.5 million for FY2024, which is 34.86% up from last year.
- According to the latest figures from Q3 2025, Exact Sciences' Cash from Operations is $219.9 million, which was up 147.06% from $89.0 million recorded in Q2 2025.
- In the past 5 years, Exact Sciences' Cash from Operations ranged from a high of $219.9 million in Q3 2025 and a low of -$173.8 million during Q1 2022.
- Moreover, its 3-year median value for Cash from Operations was $69.5 million (2023), whereas its average is $64.2 million.
- Per our database at Business Quant, Exact Sciences' Cash from Operations soared by 687.15% in 2021 and then slumped by 251.02% in 2022.
- Over the past 5 years, Exact Sciences' Cash from Operations (Quarterly) stood at -$24.6 million in 2021, then skyrocketed by 311.77% to $52.0 million in 2022, then spiked by 33.65% to $69.5 million in 2023, then plummeted by 32.33% to $47.1 million in 2024, then soared by 58.54% to $219.9 million in 2025.
- Its Cash from Operations stands at $219.9 million for Q3 2025, versus $89.0 million for Q2 2025 and $30.8 million for Q1 2025.